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Abstract
Four Quarter Horses (1 'filly age 2, 1 mare age 5 and 2 geldings ages 3 and 4; average weight 539
kg) were used in a 2 x 2 crossover design. The effects of furosemide (Lasix(Rx» on arterial blood
packed ceii voiume (PCV), hemogiobin (Hb), pH, p02, pC02, HCO-3 and base excess (BE) \,AJere
measured. Plasma lactate, heart rate, and fatigue time were determined as indicators of perlormance
while the horses performed a fatigue test on a high-speed treadmill. The left carotid artery was
surgically elevated subcutaneously to facilitate collection of arterial blood samples. Horses were
conditioned for 13 weeks with increasing intensity then randomly assigned furosemide (F) or physi-
ological saline (C) as treatments. Treatments were administered 4 hours prior to the fatigue test in
accordance with racing regulations. Arterial blood samples were collected prior to treatment dose,
prior to exercise, at the 2nd, 4th, and 6th minute during the fatigue test, at fatigue, and at the 5th,
15th, 30th, and 45th minute post-exercise. Arterial blood samples were analyzed for blood gases,
Hb, PCV, and plasma lactate. Heart rate and fatigue time were recorded. No difference between
treatments (P > 0.05) was observed for blood gases except for pC02 at rest, and HCO-3 and BE at
the 2 minute collection period. No difference between treatments (P > 0.05) was observed for Hb,
PCV, lactate and heart rate except at 15 minutes post-exercise for Hb and PCV, and 45 minutes post-
exercise for Hb. Fatigue times were 11 min 56 sec ± 5 min 30 sec for F horses and 11 min 35 sec--±
2 min 6 sec for C horses. No difference (P > 0.05) was observed in fatigue time. Based on our data,
the trend indicated that all parameters measured returned to pre-exercise levels more rapidly for
furosemide treated horses. However, furosemide did not enhance performance.
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Introduction
Exercise Induced Pulmonary Hemorrhage
(EIPH) is a respiratory disorder that occurs in 50
- 70% of horses subjected to strenuous exercise.
It is characterized by bleeding from the respira-
tory tract originating beyond the trachea, usually
from the lung. The etiology of EIPH is still not
known14.
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In a recent workshop on EIPH, several areas
of needed research were discussed inclUding the
development of effective prophylactic and
therapeutic approaches to treating and prevent-
ing EIPH15. Currently, the drug Furosemide
(Lasix®» is routinely used as a prophylactic for
EIPH. Furosemide is a diuretic and produces its
effect within minutes of injection6. Due to the
diluting effect furosemide has on the detection of
other drugs in the urine, it must be administered
four hours prior to racing and the dose (250 mg)
is regUlated by state racing commissions1. Since
most of the physiological effects of the drug
occur within the first hour of adn1inistration, why it
is thought to improve the performance of EIPH
horses four hours later during exercise is
unclear. It has been shown that 60% or more of
'furosemide treated racehorses will still bleed
after a race16. The mechanism of action for
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furosemide's prevention or reduction in severity
of EIPH is not known and there is no clear
evidence that it is effective in preventing or
reducing the severity of an EIPH episode14.
Studies have shown conflicting results on
whether furosemide improves the racing
performance of EI PH horses or healthy race-
horses16.
In humans, furosemide increases arterial
oxygen tension suggesting an improvement in
gas exchange within the lung. It is believed that
the improvement in gas exchange is due to a
reduction in intrapulmonary shunting of blood6.
In horses, when 'furosemide is administered 4
hours prior to exercise, it has been shown to
reduce right atrial and pulmonary arterial
pressures and the reduction in pressure is dose
dependent11 . The effect of 'furosemide on arterial
blood gases when administered at the racing
regulated dose of 250 mg 4 hours prior to
exercise has not been investigated. The
objective of this study was to determine the effect
of a 250 mg dose of 'furosernide administered 4
hours prior to exercise on arterial blood gases
and performance while horses were exercised to
fatigue on a treadmill.
Materials and Methods
Four Quarter Horses were used in a 2x2
crossover design to evaluate the effect of
furosemide on arterial blood packed cell volume
(PCV), hemoglobin (Hb), pH, p02' pC02,
bicarbonate (HC03), base excess (BE), and
performance, using plasma lactate, heart rate
and fatigue time as indicators of fitness. The left
carotid artery was surgically elevated to form a
subcutaneous loop in each horse2. Horses were
housed in outdoor paddocks and fed a diet of
grain mix and grass hay. Each horse was
conditioned with increasing intensity 5 days a
week for 13 weeks on a high speed treadmill
(Sato 11)13. Horses were randomly assigned one
of two treatments, furosemide (F) or a physiologi-
cal saline placebo (C). A 5 cc treatment dose of
either 250 mg of furosemide or 5 cc of physi-
ological saline was administered intravenously
four hours prior to performing the fatigue test
(dose and time of furosemide administration in
accordance with Iowa State Racing Commission
regulations9). Horses were not allowed access to
food or water following administration of either
treatment. Four hours post-treatment, the
horses were warmed up 4 minutes at 3.35 m/s at
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an incline of 00 and then immediately tested at
6.71 m/s at an incline of 100 until fatigued.
Fatigue was determined to be the point when
the horse could no longer be encouraged off the
tail chain.
Arterial blood samples were collected prior to
dosing, at rest (before being tested on the
treadmill), 2, 4, and 6 minutes into the fatigue
test, fatigue (the point at which the horse was
stopped), and 5, 15, 30, and 45 minutes recov-
ery. The recovery period was passive. The
arterial sample taken at dose was collected via
arterial puncture. All other arterial blood samples
were taken after insertion of a 16 gauge 2 inch
arterial catheter into the elevated left carotid
artery with an extension and three-way stopcock
attached. This setup enabled 'freedom in
collection of arterial blood samples while the
horses were exercising on the treadmill. Ap-
proximately 10 cc of blood was drawn and
discarded before samples were collected and
each sample collection was followed by approxi-
mately 20 cc of saline warmed to 380aC to flush
the apparatus.
Arterial blood samples intended for blood gas
analyses were collected in heparinized glass
syringes and kept on ice until analysis. Arterial
blood samples for Hb and PCV analyses were
collected in potassium oxalate vaccutainers and
kept on ice until analysis. Arterial blood
samples for lactate analyses were collected in
sodium fluoride/potassium oxalate vaccuta.iners,
centrifuged at 4000 g for 5 minutes, plasma
extracted and 'frozen in microcentrifuge tubes
until analysis.
Heart rates were recorded by a Hippocard7
heart rate monitor at dose, rest, 2, 4, and 6
minutes of fatigue test, and 5, 15, 30 and 45
minutes recovery. The amount of time taken for
each horse to reach fatigue was also recorded in
minutes and seconds.
Arterial blood samples were analyzed for pH,
p02' pC02, HC03, and BE using an IL Blood
Gas Analyzer8 . Hemoglobin was determined by
the cyanmethemoglobin method. Packed cell
volume was determined by microhematocrit
centrifugation. Plasma lactate levels were
determined by Lactate Autoanalyzer17•
All data were analyzed for treatment effects
using GLM procedures of SAS (1989)12. Differ-
ences due to treatment were analyzed using
Least Square Means at (P < 0.05).
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Results and Discussion
Arterial blood parameters and heart rates
resulting from this study are listed in Table 1.
The p02 level of F treated horses decreased
'from a resting level of 126 to 82.17 mm Hg at 6
minutes of testing and returned to resting levels
within 5 minutes of recovery. Control p02 level
exhibited a similar pattern with values slightly
lower, however the difference between treat-
ments was not signi'ficant. The pC02level of F
and C treated horses closely followed each
other with lowest levels at fatigue and 5 minutes
recovery. These results agree with studies
conducted by Bayly et al3 and Littlejohn and
Snow10 witl1 Thoroughbred horses exercising at
7 m/sec and 1a m/sec~ respectively. Arterial
blood pH of F treated horses increased slightly
'from the dose pH of 7.415 to 7.438 when
sampled at rest. This agreed with a study
conducted by Freestone et al4 where horses
were dosed with 1 mg/kg. The pH then main-
tained a higher level for F treated horses
compared to C horses throughout testing,
fatigue and recovery. A signi'ficant difference
due to treatment was found for pH at 30 minutes
recovery (P < 0.05). The pH values are lower,
however, than the pH values reported for
Thoroughbred horses exercising at similar
speeds by Freestone et al4 and Littlejohn and
Snow1O• Bicarbonate (HC03) concentration and
BE of arterial blood exhibited a similar pattern to
pH, with a signHicant difference between
treatments at 2 minutes for HCO-3 and for BE (P
< 0.05). Packed cell volume and Hb levels
exhibited typical exercise patterns however,
values were lower than those reported by Harris
and Snows and Littlejohn and Snow10 • A large
increase in PCV from resting levels was
maintained throughout testing and a near return
to resting levels was reached at 45 minutes
recovery. Plasma lactate levels also exhibited
an increase during exercise, however F treated
horses had lower lactate concentrations
throughout recovery. Heart rate showed a
marked increase 'from rest to 6 minutes of
testing, and returned to near resting levels at 45
minutes recovery. The heart rates agreed with
the values reported by Bayly et a13 , Harris and
Snows, and Littlejohn and Snow10• The fatigue
time of F treated horses was 11 minutes and 56
seconds compared to 11 minutes a.nd 35
seconds for C horses. The difference was not
significant due to treatment.
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Conclusion
No difference between fatigue time of F
treated horses and C horses was observed
suggesting furosemide did not enhance perfor-
mance of healthy horses. Furosemide did not
appear to enhance ventilation/perfusion during
exercise as reflected by the similar response
observed between experimental groups for
arterial blood gases. A trend towards less acid/
base balance disturbance was seen for the F
treated horses, however this trend was not
significant. A similar study needs to be per-
formed on clinically diagnosed EIPH horses that
experience frequent EIPH episodes to determine
whether furosemide produces results similar to
those found in this study.
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